Oldest adults with acute myeloid leukemia benefit from Venetoclax
May 16, 2024
Octogenarians and nonagenarians can be treated successfully with VEN-HMA.
ACP: Next-generation antibiotics underused for gram-negative infections
Apr 22, 2024
41.5% of difficult-to-treat resistance episodes were treated exclusively with traditional agents.
Glycemic control superior with semaglutide 25 and 50 mg in Type 2 diabetes
Aug 04, 2023
Mean changes in HbA1c were significantly greater for semaglutide 25 mg or 50 mg versus 14 mg.
CMS announces Alzheimer’s drug coverage policy, but ‘the devil is in the details,’ experts say
By
Kimberly Bonvissuto
Jun 01, 2023
A Thursday announcement by the Centers for Medicare & Medicaid Services regarding coverage of Alzheimer’s drugs is being met with skepticism by some industry advocates who say that “the devil is in...
Focus on briefs: Resident security
By
John Hall
Dec 03, 2023
Costs, along with changing attitudes, help fuel growth in deprescribing, Older Americans have access to more vaccines than ever, but increasing numbers cause concern for some individuals
Low-dose direct oral anticoagulants tied to more bleeding episodes
Jun 19, 2024
The findings compared with standard doses in patients with atrial fibrillation.
Reteplase superior to alteplase within 4.5 hours of ischemic stroke
Jun 20, 2024
Reteplase was more likely to result in excellent functional outcome than alteplase for ischemic stroke within 4.5 hours of symptom onset.
Fewer adults eligible for statins with PREVENT equations
Jun 21, 2024
Compared with the pooled cohort equations, the mean estimated 10-year ASCVD risk was lower using the PREVENT equations across all age, sex and racial subgroups, with the largest difference seen for Black...
Medicare to cover Wegovy when patients also have heart disease
Mar 22, 2024
Medicare will now cover the popular weight-loss drug Wegovy if patients using it also have heart disease, US officials announced Thursday.
Following drop after COVID-19 onset, inappropriate antibiotic prescribing is up
May 01, 2024
An initial decrease was seen in proportion with inappropriate prescription, followed by a subsequent increase.